Lanabecestat

DB14814InvestigationalSmall molecule

Lanabecestat is under investigation in clinical trial NCT03499041 (A Study of LY3314814 in Participants With Liver Impairment).

Chemical structure of Lanabecestat
Mechanism
Curator reviewed
Formula / weight
C26H28N4O · 412.537 g/mol (avg)
Code names
AZD3293 · LY3314814

Resolves to

Compound
UNIIX8SPJ492VFCAS1383982-64-6ChEMBLCHEMBL3989948
Structure
InChIKeyWKDNQONLGXOZRG-HRNNMHKYSA-NSMILESCO[C@H]1CC[C@@]2(CC3=CC=C(C=C3[C@@]22N=C(C)C(N)=N2)C2=CC(=CN=C2)C#CC)CC1
Targets
P56817BACE1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Lanabecestat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In